Navigation Links
Pathway BioLogic is Chosen by Easy Gardener to Formulate the U.S.’s First Microbial Enhanced Natural Water Soluble Plant Food
Date:1/30/2013

availability in the soil, and optimizing the plant’s capacity to uptake and utilize these nutrients. This results in improved plant health and growth.”

Mounting research data showing the soil and plant benefits to be gained by the application of beneficial plant growth promoting bacteria are leading both the consumer and professional markets toward wider acceptance and use of proven microbial products such as those that Pathway formulates. “Seeing the breakthrough results that our emerging microbial technology is already proving, and the exciting potential in our product R&D pipeline, we are busy looking for progressive companies who want or need a microbial technology partner to develop and market innovative products that provide them with a sustainable competitive advantage”, says Mark Warren, Managing Partner and head of Business Development for Pathway. “We are pleased to be able to offer Easy Gardner some of the tools that will enable them, and the consumers that buy their products, to be successful.”

About Pathway BioLogic
Pathway BioLogic, is an emerging leader in applied microbiological technology that formulates and markets advanced microbial solutions for the Agriculture, Professional Turf, and Horticulture markets, as well as Private Label solutions for Retail Lawn & Garden. Pathway’s core agronomic focused microbial products include Merge, Matrix, Manage, NRG, and RootHoney. Pathway also provides sustainable bio-remediation and bio-augmentation solutions to complement and optimize chemical, mechanical or filtration proc
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Decades-old conclusion about energy-making pathway of cyanobacteria is corrected
2. bioTheranostics Launches Precision Medicine Biomarkers for Tumor Pathway Interrogation
3. More evidence for longevity pathway
4. Alliance for Safe Biologic Medicines Chairman Urges FDA to Ensure that Patient Safety is the Cornerstone of Biosimilar Pathway
5. Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway
6. Merrimack Pharmaceuticals To Present Preliminary Clinical Data For Novel Therapies Targeting Molecular Pathways In Advanced Cancers
7. Leuven research opens new pathway for the treatment of Alzheimers disease
8. Avaxia Biologics, Inc. Raises $2.2 Million in First Closing of Series A Financing to Advance Oral Antibodies for Inflammatory Bowel Disease
9. Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public
10. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
11. Pinnacle Biologics, Inc. Announces the Successful Completion of a Financing Round
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... 17, 2014 pH measurement and control ... the pharmaceutical, chemical, and food and beverage industries. But ... and how do pH sensors work? METTLER TOLEDO has ... in process industries with these questions and more. , ... in the process industries. The actual sensor, the pH ...
(Date:11/18/2014)... New Brunswick, NJ (PRWEB) November 18, 2014 ... of Data Quality and Transparency Reporting solutions, announced ... has gone live using its Consummate Provider™ solution ... Consummate Provider™ is a Global, SaaS based, Data ... Science organizations and their third party Providers improve ...
(Date:11/18/2014)... (PRWEB) November 18, 2014 Brothers Josh ... the launch of PAWSitively Curing Cancer, Inc . ... new 501(c) (3) non-profit organization is dedicated to raising ... goes directly to the University of Florida College ... with PAWSitively Curing Cancer as the recipient of this ...
(Date:11/18/2014)... (PRWEB) November 18, 2014 Array Architects ... and design expertise to the nation's hospitals and health ... served by those dedicating their careers to the advancement ... respected contributor in her respective field, Laura Silvoy has ... at the 2014 Winter Simulation Conference. , Laura ...
Breaking Biology Technology:pH Guide from METTLER TOLEDO Explains Measurement, Theory and Practice of pH Applications 2Alanda Software Completes Successful Implementation of Global Data Quality & Vendor Management Solution for Top Tier Global Biopharmaceutical Company 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 2PAWSitively Curing Cancer, Inc. Launched By Two Children for National Pet Cancer Awareness Month 3Array Healthcare Simulation Expert Slated to Speak at Winter Simulation Conference 2
... the Predictable Relief Provided by the Only Commercially Available ... ... in Adults, DEERFIELD, Ill., Nov. 6 Takeda Pharmaceuticals ... the first direct-to-consumer (DTC) advertising campaign for AMITIZA(R),(lubiprostone), the only ...
... HORSHAM, Pa. and KENILWORTH, N.J., Nov. 6 ... Pharma Corporation,announced today that an estimated one ... (infliximab), the leading anti-tumor necrosis,factor (TNF)-alpha therapy ... to,treat more patients worldwide than all other ...
... and VALAIS, Switzerland, Nov. 5 ,Lantibio, Inc. and TRB ... a subsidiary of Alcon, Inc. (NYSE: ACL ) ... Eye Syndrome product. The,product consists of a TRB patented ... the US under an IND by a,subsidiary of Lantibio. ...
Cached Biology Technology:'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down 2'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down 3'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 2REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 3REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 5REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 6REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 7REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 8REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 9REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 10REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 11REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 12Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 4
(Date:11/4/2014)... newly published research study examining only marketing directed ... fast food restaurants has found that the majority ... exposed to such marketing tactics. , Authored by ... colleagues, the study is the first to examine ... and exterior of fast food restaurants and its ...
(Date:11/4/2014)... 2014   Neurotechnology , a provider of ... latest version of its fingerprint matching algorithm has ... evaluation organized by NIST. The MINEX test ... INCITS 378 fingerprint standard template format. MINEX compliance ... in the United States ...
(Date:11/3/2014)... 2014  NeuroSigma ® , Inc. (NeuroSigma), a ... focused on commercialization of its non-invasive ... of neurological and neuropsychiatric disorders, announced today that ... a Notice of Allowance for Mexican Patent Application ... NeuroSigma and the Regents of the University of ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
... the University of Saskatchewan has discovered a signaling pathway in ... for blocking its action, that may point to a single ... the March issue of the prestigious journal Nature Medicine. , ... U of S department of psychiatry, found that a naturally ...
... the Forsyth Institute have discovered a new mechanism responsible ... locate themselves on the left or right side of ... mechanism, garnered through the study of three different vertebrates ... a single common mechanism has been identified in left-right ...
... Scientists generally agree that all cloned animals are biologically ... for stem cells derived from cloned embryos, the basis ... cell nuclear transfer, therapeutic cloning is a promising approach ... disorders. Demonstrated in mice but not in humans, it ...
Cached Biology News:Team discovers possible 'universal strategy' to combat addiction 2Forsyth scientists gain greater understanding of how embryos differentiate left from right 2Forsyth scientists gain greater understanding of how embryos differentiate left from right 3Cloned stem cells prove identical to fertilized stem cells 2Cloned stem cells prove identical to fertilized stem cells 3